Registration Number
0220U100674,
0117U003075
, R & D reports
Title
To study mechanisms of formation of pharmacologically resistant facial sympathalgias and to perform an experimental-morphological grounding of their neurosurgical treatment
popup.stage_title
Head
Posokhov Mykola F., Кандидат медичних наук
Registration Date
23-01-2020
Organization
State institution "Institute of Neurology, Psychiatry and Narcology, National Academy of Medical Sciences of Ukraine"
popup.description2
Report: 159 pages, 36 tables, 1 supplement and 203 references
PHARMACORESISTANCE FACIAL SYMPATHALGIA, GANGLIONITIS OF THE CERVICAL SYMPATHETIC NODES, SYNDROME OF SUPERFICIAL TEMPORAL ARTERY
Object of the study - patients with pharmacoresistance facial sympathalgia. The subject of the study - the etiopathogenetic factors of pharmacoresistance facial sympathalgia, clinical features and complex diagnosis of facial sympathalgia.
Purpose of the study: to study the clinical and pathogenetic mechanisms of formation of pharmacoresistant facial pain caused by lesions of the sympathetic nervous system; theoretical, experimental-morphological and clinical substantiation of neurosurgical treatment of patients with facial sympathalgia.
Methods of the investigation: clinical, anamnestic, neurological, neuroophthalmical, otoneurological, radiological, neuroimaging, neurophysiological, laboratory, biochemical, statistical.
The results were obtained. The main clinical forms of pharmacoresistance facial sympathalgia were studies, namely ganglionitis of the cervical sympathetic nodes and syndrome of superficial temporal artery. Selected target objects of the neurosurgical interventions in the patients with pharmacoresistance facial sympathalgia - lower cervical (stellate) sympathetic node, upper cervical sympathetic node, periarterial plexus of superficial temporal artery. Fifty-four patients with pharmacoresistance facial sympathalgia were undergone by neurosurgery interventions and the results of this surgical treatment were evaluated. Based on clinical and experimental-morphological studies, reasonable conclusions were done regarding the mechanisms of the development of pharmacoresistance facial sympathalgia and new advanced neurosurgical method of treatment of this pathology was proposed.
Product Description
popup.authors
Ena Paisa A.
Ishchenko Oksana S.
Babkina Julia A.
Baida Roman M.
Gorbynov Oleg Oleg V.
Daher Nassif Nassif I.
Zadorozhnyi Volodymyr Volodymyr V.
Kolomiichenko Yurii A.
Kutovoy Igor Igor O.
Yevgeniya Lekomtseva Yevgeniya V.
Linska Hanna V.
Lemondzhava Zaza Zaza M.
Ostra Valentyna I.
Pykhtin Olexander Olexander V.
Poliakh Ihor Ihor O.
Posokhov Mykola F.
Sitenko Lubov M.
Stepanenko Nataliya V.
popup.nrat_date
2020-04-02